This week, Mark Marex, CFA, discusses the Nasdaq Biotechnology Index (NBI) and its performance
Schlagwort-Archiv: Stock
Inside the Nasdaq Boardroom: 4 Keys to Better Meetings
Between tackling administrative tasks and reviewing information in hefty board books, board meetings may not be as productive as they can be—or should be. At Nasdaq, we tackled this issue head-on by assessing our processes and developing a playbook for best-in-class board meeting agendas. Using a secure board portal, we’ve created a framework that
Before the Board Meeting: What Your Businesses Need to Prepare
Board meetings are critical for maintaining the health and growth of the business. Due to the sheer depth and breadth of topics often discussed during these meetings, important details can get lost in the shuffle if the proper preparation isn’t done. Sometimes, board members want to ask preliminary questions or acquire more details, so they underst
From Cash to Crypto: Digital Currencies in the Traditional Economy
Money is evolving, and as more people join the Bitcoin network, the world may see a decline in the use of cash with the wider adoption of cryptocurrencies as legitimate assets.
Fighting With 1’s and 0’s: How Distributed Ledger Technology Could Disrupt the $500B Counterfeit Industry
Look around your room. Chances are that everything has been in a container, on a plane, or inside a truck at some point. The miracle of international trade is a complex beast, a series of arteries feeding goods to each corner of the globe. And most of us know nothing about it.
Shipping and Logistics in a COVID World
Shipping and Logistics in a COVID World
Crude Slides as Surging Coronavirus Cases Renew Demand Concerns
Daily energy market commentary provided by Nasdaq Corporate Solutions Advisory Services‘ Energy Team.
Micron (MU) 4th Quarter Earnings: What to Expect
Micron is set to report fourth quarter fiscal 2020 earnings results after the closing bell Tuesday.
Why CBG and Other Rare Cannabinoids Will Supplant CBD
The global cannabis market is booming: it’s set to reach $146 billion by 2025. There is a rapidly growing demand for cannabinoids, the compounds found in the cannabis plant.
Healthtech Booms As COVID-19 Startups See Cash Pour In
It’s no small secret that overall VC/PE investments are down due to the COVID-19 pandemic. However, one area that has seen a boost in investment is healthtech.